Table 1.

Baseline disease characteristics of patients in the normal, overweight, and obese BMI categories.

CharacteristicsNormal (BMI < 25), n = 69Overweight (BMI ≥ 25 to < 30), n = 102Obese (BMI ≥ 30), n = 137p
Female, n (%)46 (67)77 (75)108 (79)
SJC6619.0 (13.3)18.2 (10.6)18.2 (9.8)0.862
SJC2813.0 (6.0)12.3 (5.8)11.8 (5.5)0.358
TJC6830.0 (17.6)29.8 (16.1)33.0 (17.4)0.268
TJC2816.2 (7.3)15.8 (7.2)16.5 (7.2)0.763
CRP, mg/l13.0 (22.5)16.3 (25.3)14.2 (17.3)0.583
  Female10.1 (18.3)14.6 (22.9)14.9 (18.9)
  Male18.9 (28.7)21.7 (31.2)11.5 (9.1)
DAS28-CRP*5.8 (1.0)5.8 (1.0)5.9 (0.9)0.762
CDAI41.9 (13.5)40.2 (13.5)41.0 (12.2)0.692
HAQ-DI1.4 (0.6)1.5 (0.6)1.5 (0.6)0.288
Synovial hypertrophy34.6 (7.4)34.0 (7.4)33.1 (7.2)0.346
  Median (range)35.0 (8.0–46.0)35.0 (1.5–47.5)34.5 (6.0–45.0)
Synovial vascularity6.1 (5.5)6.5 (6.0)5.2 (4.8)0.143
  Median (range)5.5 (0.0–26.5)5.0 (0.0–25.0)4.0 (0.0–25.5)
SF-36 PCS§33.3 (8.4)31.7 (9.1)30.6 (8.0)0.113
SF-36 MCS§44.1 (13.2)45.6 (11.9)41.3 (13.1)0.033
  • Observed data are reported. Data are mean (SD) unless indicated otherwise.

  • P value for differences between groups from 1-way ANOVA.

  • * Overweight group, n = 100; obese group, n = 133.

  • Overweight group, n = 100; obese group, n = 132.

  • Overweight group, n = 101; obese group, n = 135.

  • § Normal group, n = 68; overweight group, n = 100; obese group, n = 134. BMI: body mass index; CDAI: Clinical Disease Activity Index; CRP: C-reactive protein; DAS28-CRP: 28-joint count Disease Activity Score using CRP; HAQ-DI: Health Assessment Questionnaire–Disability Index; MCS: mental component summary; PCS: physical component summary; SF-36: Medical Outcomes Study Short Form-36; SJC66: swollen joint count at 66 joints; SJC28: SJC at 28 joints; TJC68: tender joint count at 68 joints; TJC28: TJC at 28 joints.